GlassScriptPhysician profile
Michael N Tran
NPI 1649591454
$42,615.42
in general payments reported to CMS, 2019-2025
17 companies · $1,709 in 2025
The $1,709 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,890 · 2020: $14K · 2021: $349 · 2022: $16K · 2023: $3,755 · 2024: $3,461 · 2025: $1,709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,394 · Education: $3,000 · Food and Beverage: $1,522 · Travel and Lodging: $9.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,393.75 |
| Education | $3,000.00 |
| Food and Beverage | $1,522.13 |
| Travel and Lodging | $9.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,955.65 | 2019-2025 | Da Vinci Surgical System |
| Applied Medical Resources Corporation | $17,012.94 | 2022-2024 | |
| Medtronic, INC. | $3,086.30 | 2021-2025 | Ligasure, Endo Gia Ultra |
| Medical Device Business Services, INC. | $1,399.64 | 2019-2022 | |
| Ethicon US, LLC | $681.39 | 2019-2025 | Echelon Flex, Harmonic, Echelon Endopath |
| Covidien LP | $359.43 | 2019 | |
| Endogastric Solutions, INC | $327.50 | 2019-2021 | |
| Davol INC. | $317.95 | 2020 | |
| Teleflex LLC | $141.42 | 2023 | Titan Sgs Standard Gastric Stapler |
| Organogenesis INC. | $124.51 | 2023 | Puraply |
| Acell, INC. | $67.34 | 2019 | |
| W. L. Gore & Associates, INC. | $30.86 | 2024 | Gore Synecor Biomaterial |
| Becton, Dickinson and Company | $29.11 | 2023 | Phasix Mesh |
| Novo Nordisk INC | $28.53 | 2023 | Rybelsus, Ozempic, Wegovy |
| Octapharma USA, INC. | $18.73 | 2025 | Fibryga |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trevena, INC. | $17.30 | 2021 | |
| Boston Scientific Corporation | $16.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.